|
| |
| | | 62755 | | 19.05.2014 | | Astellas Pharma AG | | | | | | | | | | | | | 05.02. | | | | 05.02. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Betmiga 25 mg | Retardtabletten | Delayed release tablets (Mirabegronum 25 mg) | G04BD12 | CI | | 02 | Betmiga 50 mg | Retardtabletten | Delayed release tablets (Mirabegronum 50 mg) | G04BD12 | CI |
|
|
|
